Yan Zhang Bixiu He Dongbo Zhou Min Li Chengping Hu
10.2147/OTT.S188612
Onco Targets Ther
2018 Dec 18;12:51-56.
egfr mutation nsclc next-generation sequencing tyrosine kinase inhibitor
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/30588029/
Case Reports
PMC6302808
30588029
Newly emergent acquired EGFR exon 18 G724S mutation after resistance of a T790M specific EGFR inhibitor osimertinib in non-small-cell lung cancer: a case report
2018